they never did - nor do they now - have anything near term revenue producing and financially sustaining
Gerald went on a $34-Mil. spending spree, ($40-Mil. all in) on credit, and bought absolutely nothing that could sustain the company, these newly acquired assets could only create greater expenses and longer term developmental costs
nice financial engineering, eh? this security will continue to dilue daily until such time as they bring in a cash rich partner, or divest in worthless assets such as NuroPro. SeraPro, PhenoGuard and the Georgetown assays
in essence, Gerald extended the cash burn runway with no way to support the company, except for toxic convertibles, which caused him to loose ownership of the company, and its IP, while taking the loyal shareholders to their fatal demise
maybe the company and its IP were actually sacrificial, in that there was no near term revenue inherent in the company and its IP - only forward looking projects of what the therapeutics and diagnostics "might" be worth one day - multiple years off
AMBS Business Model 101 - doomed to fail
buy used, unwanted assets on the cheap, better them, and then hope like hell to pawn them off on to someone else for more money
News 
Market Data 
Discover 
